title: Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).
authors.affiliation: Division of Hematology, Oncology, and Stem Cell Transplantation, Rush University Medical Center, Chicago, IL 60612, USA, iva_cela@rush.edu
authors.forename: Iva
authors.initials: I
authors.lastname: Cela
authors.forename: Ira J
authors.initials: IJ
authors.lastname: Miller
authors.forename: Robert S
authors.initials: RS
authors.lastname: Katz
authors.forename: Amy
authors.initials: A
authors.lastname: Rizman
authors.forename: Jamile M
authors.initials: JM
authors.lastname: Shammo
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D001855:Bone Marrow Diseases / Q000209:etiology / Q000628:therapy; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008533:Megakaryocytes / Q000187:drug effects / Q000473:pathology; D008875:Middle Aged; D018716:Molecular Mimicry; D011696:Purpura, Thrombocytopenic / Q000209:etiology / Q000628:therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; C520809:eltrombopag